Address:Kino Tower 17th Floor

Jl. Jalur Sutera Boulevard No. 01, Alam SuteraPanunggangan Timur, Pinang

Tangerang City 15143, Banten, Indonesia

Company PresentationQuarter 1 - Year 2020

PT Kino Indonesia Tbk

1

Kino Corporate OverviewKey Milestones

• Restructuring of PT Kinocare Era Kosmetindo to become PT Kino Indonesia

• Kino International Pte. Ltd. became the holding of overseas branches

Kino International Pte. Ltd. and Kino Vietnam Co. Ltd. were established

PT Kinocare Era Kosmetindo obtained license from Wen Ken Drug Pte. Ltd. to manufacture, market, and distribute “Cap Kaki Tiga” in Indonesia

PT Kino Sentra Industrindo was established to produce confectioneries, foods and powdered drinks, and PT Kinocare Era Kosmetindo was established to produce toiletries, cosmetics, personal care, beverages and pharmaceuticals

Kino Care (M) Sdn. Bhd. and Kino Consumer Philippines Inc. were established

PT DutalestariSentratama was established as a distribution company

199119971999

20032004

2011 2013 2014 2015 2016 2017 20192018

▪ PT Kino Indonesia Tbk has officially acquired 51% shares on PT Kino Food Indonesia from Morinaga & Co., Ltd.

▪ LinandaConsumer India Pvt. Ltd. was established

• PT Kino Ecomm Solusindowas established

• PT Kino Indonesia Tbkobtained license from Wen Ken Drug Pte. Ltd. to manufacture, market, and distribute “SejukSegar” in Indonesia

• PT Kino Malee Indonesia and Malee Kino (Thailand) Company Limited were established as JV companies with MaleeCapital Company Limited

PT Kino Indonesia Tbklisted its shares in Indonesia Stock Exchange

• PT Kino Indonesia Tbk acquired “DuaPutri Dewi”, a traditional herbal medicine brand

• PT Kino Indonesia Tbk acquired the business of RistraGroup and formed PT Ristra LaboratorisIndonesia and PT Ristra KlinikIndonesia

• PT Kino Pet World Indonesia dan PT Kino Pet World Marketing Indonesia were established as JV companies with Wah Kong Corporation Sdn Bhd

• PT Kino Indonesia Tbk added shares until 100% on PT Ristra Laboratoris Indonesia and PT Ristra Klinik Indonesia

• Kino Care Consumer (Cambodia) Co., Ltd. was established as JV company with VSCP Investment Co., Ltd.

2

PT RistraLaboratorisIndonesia

PT RistraKlinik

Indonesia

Kino Consumer Philippines Inc.

Kino International

Pte. Ltd.

PT DutalestariSentratama (2)

PT Kino Food

Indonesia(3)

PT Kino Indonesia Tbk

Mr Harry SanusiPT Kino Investindo(1)

Kino Vietnam Co., Ltd

Kino Care (M) Sdn.

Bhd.

9.98% 69.5%

80.4% 99%99%100%99.97%

Public

20.52%

PT Kino Ecomm

Solusindo

99.67%

PT Kino MaleeIndonesia(4)

51%

100% 100% 100%

PT Kino MaleeTrading(5)

99.93%

Malee Kino (Thailand) Company Limited

49%

PT Kino Pet World Indonesia(6)

PT Kino Pet World Marketing Indonesia(6)

51% 51%

Kino Care Consumer (Cambodia) Co., Ltd.(7)

51%

LinandaConsumer India Pvt. Ltd.(8)

99.75%

Kino Corporate Structure

(1) 99% held by Mr. Harry Sanusi and 1% held by Mr. Ali Sanusi(2) the remaining 0.1% is held by Mr. Harry Sanusi(3) the remaining 19.6% is held by Mr. Harris Sanusi.(4) the remaining 49% is held by Malee Capital Company Limited, an independent third party(5) the remaining 0.07% is held by PT Kino Indonesia Tbk(6) the remaining 49% is held by Wah Kong Corporation Sdn Bhd, an independent third party(7) the remaining 49% is held by VSCP Investment Co., Ltd., an independent third party(8) the remaining 0.25% is held by PT Kino Indonesia Tbk

3

Target Consumers

◼ Middle and high income ◼ Middle and high income(1) ◼ Low, middle and high income ◼ Low and middle income

Personal Care (17) Beverage (5) Foods & Pet Food (8) Pharmaceutical (3)

▪ Hair CareEllips, Samantha, Sasha

▪ Remedy DrinksCap Kaki Tiga, Cap Kaki TigaAnak, Sejuk Segar

▪ ConfectioneryKino Candy, Chew2Ball, Frenta, Oplozz

▪ Herbal cough, balm, Skin Ointment, Ringworm MedicineCap Kaki Tiga

▪ Oral CareSasha

▪ Energy DrinksPanther

▪ Powdered DrinksSegar Sari

▪ Kids Personal Care and Baby Eskulin Kids, B&B Kids, Master Kids,Sleek

▪ Asian DrinksCap Panda

▪ SnackSnack It, PIA 100, Sekar Harum

▪ Traditional Herbal MedicineDua Dewi, Lola Remedios

▪ Feminine HygieneResik-V, Absolute

▪ Skin CareOvale, Ristra, Platinum, Trustee

▪ JuiceMalee, Malee Coco

▪ Dog FoodProbalance

▪ FragranceEskulin, Master

Joint venture with Malee Group Public Limited, a Thai beverage player

▪ Cat FoodProdiet

▪ Air FreshenerEvergreen

Joint venture with Wah Kong Corporation Sdn. Bhd., a Malaysian conglomerate company

▪ DecorativeAbstract

Key Segments & Brands

34 Brands

23 Categories

(1) High income customers targeted through premium brands access is JV with Malee

4

(1) Contribution percentages and Rupiah financial metrics are as of YTD Dec’19

Q1 – Financial Contribution

Segment Revenue (1)

(in Billion Rp)

Gross Profit (1)

(in Billion Rp)

Personal Care 555 323

Beverages 412 175

Food & Pet Food 110 34

Pharmaceutical 36 23.7

Total revenue as of YTD Mar’20: Rp1,113bn

50%

37%

10%3%

Revenue Contribution

PC Bev Food & Pet Food Phar

Total gross profit as of YTD Mar’20: Rp555,7bn

58%32%

6% 4%

Gross Profit Contribution

PC Bev Food & Pet Food Phar

5

JAVA: 74 direct reach

distribution outlets

EAST INDONESIA: 18

direct reach distribution outlets

SULAWESI: 32 direct reach

distribution outlets

KALIMANTAN: 32 direct reach

distribution outlets

SUMATERA: 104 direct reach

distribution outlets

BALI & NUSA TENGGARA: 16 direct reach

distribution outlets

DLS: 2 branches

DLS: 6 branchesDLS: 3 branches

DLS: 4 branches

DLS: 9 branches

DLS: 9 branches

National network provides broadest platform for growth and drives cost synergies

All products in Indonesia channeled through our proprietary distribution business DLS

Company-owned branches primarily in Java and Bali regions: highest populations and spending power

Engage local distributors in other areas to expand reach in a capital-lite manner and leverage on-the-ground knowledge

Key features

1

2

3

4

◼ Total distribution points of sale: 1.2m

‒ 33 DLS branches

‒ 164 local distributors / 276 direct reach distribution outlets

(1) As of 30th September 2019

Leadership underpinned by deep local distribution

6

Apart from local region, penetration has also being done towards international markets

7

Leading portfolio of personal care brands in attractive segments

8

(Rp, billions)

1,801

2,188

516 555

2018 2019 YTDMar'19

YTDMar'20

(Rp, billions)

1,0301,203

282 323

2018 2019 YTDMar'19

YTDMar'20

Brands

and

products

Key segments

Rev

en

ue

Gro

ss P

rofi

t

Growing portfolio of beverage brandsAttractive mix of functional local beverages

9

(Rp, billions)

1,528

1,762

360 412

2018 2019 YTDMar'19

YTDMar'20

(Rp, billions)

593716

136 175

2018 2019 YTDMar'19

YTDMar'20

Brands

and

products

Rev

en

ue

Gro

ss P

rofi

t

Growing portfolio of food and pet food brandsCurrent food offering includes a variety of candy and snacks, and pet foods offers wide

choices for cats and dogs

10

(Rp, billions)

255

445

88 110

2018 2019 YTDMar'19

YTDMar'20

(Rp, billions)

4

70

12

34

2018 2019 YTDMar'19

YTDMar'20

Brands

and

products

SnacksCandy

Cat FoodDog Food

Rev

en

ue

Gro

ss P

rofi

t

11

Brands

and

products

Significant portfolio growth of pharmaceutical brandMainly derived from the enormous performance of Lola Remedios in Philippines

Rev

en

ue

Gro

ss P

rofi

t

(Rp, billions)

27

284

38 36

2018 2019 YTDMar'19

YTDMar'20

17

192

24 23.7

2018 2019 YTDMar'19

YTDMar'20

(Rp, billions)

259

306

803

348

125

8.2% 8.5%

17.2%

11.2%

2017 2018 2019 YTDMar'19

YTDMar'20

EBITDA EBITDA margin

34.7%

3,161

3,612

4,679

1,0021,113

42.1% 45.5% 46.8% 45.3% 49.9%

2017 2018 2019 YTDMar'19

YTDMar'20

Net revenue Gross margin

EBITDA and EBITDA Margin Net income and net income marginNet Revenue and Gross Margin(Rp in billions) (Rp in billions) (Rp in billions)

Note: EBITDA defined as income before income tax expenses + interest expenses + bank admin expenses + depreciation expenses + amortization expenses.

Net income excludes other comprehensive income mainly related to property revaluations.

EBITDA and Net profit on 2019 include gain on bargain purchase amounted to Rp 264 biliion.

EBITDA: Without gain, YTD Mar increased 48.13% YoY ; Net profit: Without gain, YTD Mar increased 45.73% YoY

110

150

516

304

58

3.5% 4.2%

11.0%

5.2%

2017 2018 2019 YTDMar'19

YTDMar'20

Net income Net income margin

30.2%

Comprehensive income including valuation gainsrelated to property revaluation

121

534

179

Track record of profitable growth

12

91

303